SEC Filing Summary: Chavant Capital Acquisition Corp. (CLAY)
Business Context and Reporting Period
This Form 8-K, dated January 6, 2023, reports on Chavant Capital Acquisition Corp. (the "Company"), a Cayman Islands-based special purpose acquisition company (SPAC). The filing details the approval of an extension to the deadline for consummating an initial business combination and the issuance of a promissory note to fund trust account deposits. The Company is in the process of a proposed business combination with Mobix Labs, Inc., pursuant to an agreement dated November 15, 2022.
Key Financial Metrics and Capital Structure
- Promissory Note: Issued an unsecured convertible note to its Sponsor, Chavant Capital Partners LLC, with an aggregate principal amount of up to $300,000.
- Trust Account Deposit: Made an initial deposit of $42,802.10 into the Trust Account following shareholder approval of the extension. This represents a rate of $0.05 per non-redeeming public share per month.
- Redemptions: Shareholders holding 96,991 ordinary shares exercised their right to redeem shares for a pro rata portion of the Trust Account funds.
- Debt Terms: The note bears no interest. It is convertible into private placement warrants at $1.00 per warrant upon the consummation of a business combination. The maturity date is July 31, 2024.
- Liquidity: Funds from the note are used for working capital and trust deposits. Repayment is expected from Trust Account proceeds if a business combination closes, or from working capital outside the Trust Account if it does not.
Material Changes and Corporate Actions
- Extension of Deadline: Shareholders approved an amendment to extend the date by which the Company must consummate an initial business combination from January 22, 2023, to July 22, 2023.
- Voting Results: Approximately 91.87% of entitled shares were present. The Extension Amendment Proposal received 2,694,454 votes "For" and 18,562 votes "Against."
- Share Count Impact: The redemption of 96,991 shares reduced the number of public shares outstanding, affecting the monthly deposit requirement into the Trust Account.
Outlook, Risks, and Management Commentary
The Company intends to file a Registration Statement on Form S-4 regarding the proposed transaction with Mobix Labs. Management highlights that the extension provides additional time to complete the business combination. However, the filing contains extensive forward-looking statements subject to significant risks, including:
- Failure to complete the proposed transaction with Mobix Labs in a timely manner or at all.
- Inability to satisfy conditions for the transaction, such as minimum cash requirements post-redemption.
- Volatility in the price of securities due to macroeconomic factors, supply chain issues, and U.S./China trade tensions.
- Risks related to Mobix Labs' ability to achieve profitability, secure additional capital, and protect intellectual property.
- Potential disruption to Mobix Labs' business operations and employee retention during the transaction process.
Investor Verification Checklist
- Verify the final number of non-redeeming public shares to confirm the ongoing monthly deposit obligation of $42,802.10.
- Monitor the status of the Form S-4 registration statement and the definitive proxy statement/prospectus for the Mobix Labs transaction.
- Confirm whether the Sponsor elects to convert the $300,000 promissory note into private placement warrants or requires cash repayment by July 31, 2024.
- Review the "Risk Factors" section in the upcoming proxy statement for updated details on regulatory approvals and minimum cash conditions.
- Assess the impact of the 96,991 share redemptions on the total cash available in the Trust Account for the proposed merger.